Standard dosing ranges from 200 to 500mcg per day for most adult protocols
study involving patients with type 2 diabetes and cardiovascular disease, those who received GLP-1 therapies experienced a 20 percent reduction in hospital admissions compared with individuals on non-GLP-1 treatments.[157] In the United Kingdom, a modeling study projects that integrating GLP-1 therapies as part of a broader, proactive approach to diabetes management could prevent approximately 171,000 hospitalizations and generate more than $2 billion in direct cost savings by 2040.[158] Beyond direct health care savings, GLP-1 therapies offer the potential to strengthen the broader labor market
Personal Risk Factors That May Limit Eligibility Beyond formal contraindications, personal medical history shapes semaglutide suitability
Fasting glucose measures the sugar in your blood when you have not eaten anything for at least 8 hours
During this period, your body is adapting to reduced appetite, changes in digestion, and potentially lower caloric intake